专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明授权

US06310302B1 Wiring structure of wire and wiring method 失效
标题翻译：导线接线结构及布线方法
公开(公告)号：US06310302B1
公开(公告)日：2001-10-30
申请号：US09225320
申请日：1999-01-05
申请人： Toshiyuki Mori
发明人： Toshiyuki Mori
IPC分类号： B21F1502
CPC分类号： B60R16/0207 , H01L2224/78301 , Y10T29/49155
摘要： A wire is arranged on a base and pushed to the base with tips. Then, the tips are welded to the base while pushing the tips to the base, thereby to fix the wire to the base and conduct a wiring of the wire on the base in order. Firstly, these wire arranging process and tip welding process are applied to a wiring starting point of the wire, and then the next wire arranging process and tip welding process are applied to the next fixing point of the wire in order.
摘要翻译：电线布置在基座上，并用尖端推到底座。然后，将尖端焊接到基座上，同时将尖端推向基座，从而将导线固定到基座上，并且将导线依次导向基座上。首先，将这些布线处理和尖端焊接处理应用于线的布线起点，然后依次将下一个布线处理和尖端焊接处理施加到下一个固定点。

22. 发明授权

US5945637A Terminal attachment structure having a cradle portion to prevent tottering of the terminal 失效
标题翻译：端子安装结构具有支架部分以防止端子的转动
公开(公告)号：US5945637A
公开(公告)日：1999-08-31
申请号：US821449
申请日：1997-03-21
申请人： Makoto Katsumata , Toshiyuki Mori , Hitoshi Ushijima
发明人： Makoto Katsumata , Toshiyuki Mori , Hitoshi Ushijima
IPC分类号： H01R43/20 , H05K1/11 , H05K1/18 , H05K3/32 , H05K3/34 , H01R9/09
CPC分类号： H01R43/205 , H01R12/57 , H01R12/58 , H05K3/32 , H05K1/117 , H05K3/3405
摘要： A terminal attachment structure includes a circuit assembly and a terminal attached to the circuit assembly. The circuit assembly has an insulating substrate and a circuit printed on the insulating substrate. The terminal is composed of a circuit-contact part, a connecting part to be connected with a mating terminal and a cradle part arranged between the circuit-contact part and the connecting part. When a force directing the insulating substrate is applied on the connecting part, the cradle part operates to receive the force. Accordingly, the circuit-contact part does not rise from the insulating substrate, so that tottering of the terminal against the circuit assembly can be prevented.
摘要翻译：端子附接结构包括电路组件和连接到电路组件的端子。电路组件具有绝缘基板和印刷在绝缘基板上的电路。端子由电路接触部分，与配合端子连接的连接部分和布置在电路接触部分和连接部分之间的支架部分组成。当将引导绝缘基板的力施加在连接部分上时，支架部分操作以接收力。因此，电路接触部分不会从绝缘基板上升，从而可以防止端子抵靠电路组件。

23. 发明授权

US5459953A Manifold valve 失效
标题翻译：歧管阀
公开(公告)号：US5459953A
公开(公告)日：1995-10-24
申请号：US241584
申请日：1994-05-12
申请人： Yoshihiro Fukano , Yoshitada Doi , Toshiyuki Mori
发明人： Yoshihiro Fukano , Yoshitada Doi , Toshiyuki Mori
IPC分类号： F16K27/00 , F15B13/00 , F15B13/08 , F16K31/06 , F15B13/043
CPC分类号： F15B13/0839 , F15B13/0817 , F15B13/0857 , F15B13/0896 , Y10T137/86614 , Y10T137/87209 , Y10T137/87885
摘要： In order to provide a manifold valve in which the overall height thereof can be lowered, a manifold base 10 is constituted by a fitting portion 18 with tube fittings 26, 28 being attached to output openings 22, 24 which open in a vertical direction on one side surface of the fitting portion 18, and a base portion 20 having a height lower than that of the fitting portion 18. A directional control valve 12 is constituted by a main valve 60 and a pilot valve 62 which is displaced upwardly from the main valve and attached at a height approximately equal to a difference in height between the fitting portion 18 and the base portion 20 from a lower surface of the main valve 60. The main valve 60 is disposed on the base portion 20, and the pilot valve 62 is disposed on or adjacent the fitting portion 18, wherein the directional control valve 12 is integrated with the manifold base 10. Since the height of the base portion 20 can be lowered owing to the displacement of the attachment position of the pilot valve 62 with respect to the main valve 60, the entire height and length of the manifold valve can be reduced.
摘要翻译：为了提供其整体高度可以降低的歧管阀，歧管基座10由装配部分18构成，配管部分26,28被附接到输出开口22,24，输出开口22,24在一个垂直方向上打开装配部分18的侧表面和高度低于装配部分18的高度的基部20.方向控制阀12由主阀60和从主阀向上移位的先导阀62构成并且从主阀60的下表面附近高度大致等于装配部18与基部20之间的高度差。主阀60设置在基部20上，先导阀62为设置在配合部分18上或邻近装配部分18，其中方向控制阀12与歧管基座10一体化。由于底座部分20的高度可以由于附接位置先导阀62相对于主阀60，可以减小歧管阀的整体高度和长度。

24. 发明授权

US5089448A Silicon nitride sintered body having excellent high-temperature strength and method of producing same 失效
标题翻译：具有优异的高温强度的硅氮化物烧结体及其生产方法
公开(公告)号：US5089448A
公开(公告)日：1992-02-18
申请号：US632423
申请日：1990-12-24
申请人： Yasunobu Kawakami , Kagehisa Hamazaki , Toshihiko Arakawa , Toshiyuki Mori
发明人： Yasunobu Kawakami , Kagehisa Hamazaki , Toshihiko Arakawa , Toshiyuki Mori
IPC分类号： C04B35/584 , C04B35/593 , C04B35/626
CPC分类号： C04B35/584 , C04B35/5935
摘要： A silicon nitride sintered body having a composition of 1.5-3.0 weight % of Y.sub.2 O.sub.3, 0.1-1.0 weight % of Al.sub.2 O.sub.3 and balance substantially Si.sub.3 N.sub.4, a weight ratio of Y.sub.2 O.sub.3 /Al.sub.2 O.sub.3 being 2.5 or more, which has a density of 3.0 g/cm.sup.3 or more and has a structure in which the minor axes of grains are substantially 6 .mu.m or less. This silicon nitride sintered body is produced by preparing a powder mixture containing Y.sub.2 O.sub.3 powder, Al.sub.2 O.sub.3 powder and silicon nitride powder in the above proportions, the silicon nitride powder having an oxygen content of 1.2 weight % or less, a specific surface area of 9-11 m.sup.2 /g and a metal impurity content of 200 ppm or less; and sintering the powder mixture at a temperature of 1900.degree.-2100.degree. C. and a pressure of 5 kg/cm.sup.2 G or more in a nitrogen atmosphere.

25. 发明授权

US5032556A Preparation method for zircon powder 失效
标题翻译：锆石粉的制备方法
公开(公告)号：US5032556A
公开(公告)日：1991-07-16
申请号：US481335
申请日：1990-02-20
申请人： Toshiyuki Mori , Yoshitaka Kubota , Takashi Mitamura , Hidehiko Kobayashi
发明人： Toshiyuki Mori , Yoshitaka Kubota , Takashi Mitamura , Hidehiko Kobayashi
IPC分类号： C01B33/20 , C04B35/48
CPC分类号： C01B33/20 , C04B35/481
摘要： A preparation method for zircon powder, which comprises heating a feed powder mixture comprising:(1) silica and zirconia obtained by subjecting a liquid having a pH of not higher than 8 and containing silica and zirconia in a SiO.sub.2 /ZrO.sub.2 molar ratio of substantially 1/1, to liquid-removing treatment, and(2) zircon in an amount of at least 0.1% by weight based on the total amount of said silica and zirconia,at a heating rate of not higher than 5.degree. C./min from 1,200.degree. C. to a calcination temperature, and maintaining it at a calcination temperature of from 1,300.degree. to 1,700.degree. C. for from 1.0 to 24 hours.

26. 发明授权

US08563551B2 Method for preventing or treating a disease related to the glucocorticoid receptor 失效
标题翻译：预防或治疗与糖皮质激素受体有关的疾病的方法
公开(公告)号：US08563551B2
公开(公告)日：2013-10-22
申请号：US13135256
申请日：2011-06-30
申请人： Mamoru Matsuda , Masato Nagatsuka , Toshiyuki Mori , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
发明人： Mamoru Matsuda , Masato Nagatsuka , Toshiyuki Mori , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
IPC分类号： A61K31/535
CPC分类号： C07D401/12 , C07D215/14 , C07D405/12 , C07D409/12 , C07D409/14 , C07D417/12
摘要： A method for preventing or treating a disease related to the glucocorticoid receptor involving administering a pharmacologically effective amount of a 1,2-dihydroquinoline compound or a pharmaceutically acceptable salt thereof.
摘要翻译：一种预防或治疗涉及糖皮质激素受体的疾病的方法，包括施用药理学有效量的1,2-二氢喹啉化合物或其药学上可接受的盐。

27. 发明授权

US08193187B2 1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity 失效
标题翻译：具有引入其中具有磺酸酯结构或磺酰胺结构的苯基取代基的1,2,3,4-四氢喹喔啉化合物，并具有糖皮质激素受体结合活性
公开(公告)号：US08193187B2
公开(公告)日：2012-06-05
申请号：US12451653
申请日：2008-05-29
申请人： Mamoru Matsuda , Toshiyuki Mori , Masato Nagatsuka , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
发明人： Mamoru Matsuda , Toshiyuki Mori , Masato Nagatsuka , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
IPC分类号： A61K31/495
CPC分类号： C07D241/44 , C07D405/12 , C07D409/12
摘要： The compounds represented in general formula (1) or a salt thereof are useful for glucocorticoid receptor modulators. In the formula, R1 represents a lower alkyl group, a lower cycloalkyl group, an aryl group and the like; R2 represents a hydrogen atom, a lower alkyl group and the like; R3 represents a hydrogen atom, a lower alkyl group and the like; R4 and R5 represent a hydrogen atom, a lower alkyl group and the like; R6 represents a hydrogen atom, a lower alkyl group and the like; R7 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group and the like; W represents an oxygen atom, a sulfur atom, NR8 and the like; R8 represents a hydrogen atom, a lower alkyl group and the like; X represents an oxygen atom or a sulfur atom; Y represents a lower alkylene group and the like; Z represents an oxygen atom, a sulfur atom, NR9, OCO or OSO2; R9 represents a hydrogen atom, a lower alkyl group and the like respectively.
摘要翻译：通式（1）表示的化合物或其盐可用于糖皮质激素受体调节剂。在该式中，R 1表示低级烷基，低级环烷基，芳基等; R2表示氢原子，低级烷基等; R3表示氢原子，低级烷基等; R4和R5代表氢原子，低级烷基等; R6表示氢原子，低级烷基等; R7表示氢原子，低级烷基，低级烯基等; W表示氧原子，硫原子，NR 8等; R8表示氢原子，低级烷基等; X表示氧原子或硫原子; Y表示低级亚烷基等; Z表示氧原子，硫原子，NR 9，OCO或OSO 2; R 9分别表示氢原子，低级烷基等。

28. 发明申请

US20120129866A1 METHODS FOR PREVENTING OR TREATING METABOLIC DISEASES, INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, ALLERGIC DISEASES, CENTRAL NERVOUS SYSTEM DISEASES, CARDIOVASCULAR DISEASES, HOMEOSTASIS-RELATED DISEASES OR GLAUCOMA 失效
标题翻译：用于预防或治疗代谢性疾病，炎性疾病，自发性疾病，过敏性疾病，中枢神经系统疾病，心血管疾病，家养病相关疾病或GLAUCOMA的方法
公开(公告)号：US20120129866A1
公开(公告)日：2012-05-24
申请号：US13364680
申请日：2012-02-02
申请人： Mamoru Matsuda , Toshiyuki Mori , Masato Nagatsuka , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
发明人： Mamoru Matsuda , Toshiyuki Mori , Masato Nagatsuka , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
IPC分类号： A61K31/4985 , A61P29/00 , A61P37/00 , A61P37/08 , A61P25/00 , A61P25/28 , A61P27/06 , A61P3/04 , A61P3/10 , A61P11/00 , A61P11/06 , A61P3/00 , A61P9/00
CPC分类号： C07D241/44 , C07D405/12 , C07D409/12
摘要： A method for preventing or treating a metabolic disorder, an inflammatory disease, an autoimmune disease, an allergic disease, a central nervous system disease, a cardiovascular disease, a homeostasis-related disease or glaucoma, involving administering a compound or a salt thereof, the compound having the following formula (1) wherein R1 represents alkyl, cycloalkyl, aryl, heterocyclic or aralkyl; R7 represents cycloalkyl, aryl or heterocyclic; W represents oxygen or NR8, Y represents alkylene, Z represents oxygen, sulfur, OCO or NR9; R2, R3, R4, R6, R8 and R9 represent hydrogen or alkyl.
摘要翻译：一种预防或治疗代谢紊乱，炎性疾病，自身免疫性疾病，过敏性疾病，中枢神经系统疾病，心血管疾病，体内平衡相关疾病或青光眼的方法，涉及其化合物或其盐的给药，具有下式（1）的化合物，其中R 1表示烷基，环烷基，芳基，杂环或芳烷基; R 7表示环烷基，芳基或杂环; W表示氧或NR8，Y表示亚烷基，Z表示氧，硫，OCO或NR9; R2，R3，R4，R6，R8和R9表示氢或烷基。

29. 发明授权

US08088729B2 Anti-viral griffithsin compounds, compositions and methods of use 有权
标题翻译：抗病毒性灰质素化合物，组合物和使用方法
公开(公告)号：US08088729B2
公开(公告)日：2012-01-03
申请号：US12095697
申请日：2006-12-01
申请人： Barry O'Keefe , Toshiyuki Mori , James B. McMahon
发明人： Barry O'Keefe , Toshiyuki Mori , James B. McMahon
IPC分类号： A01N37/18 , A61K38/00 , A61P31/12 , C07K1/00
CPC分类号： A61K38/168
摘要： A method of inhibiting a viral infection of a host comprising administering to the host an anti-viral griffithsin polypeptide comprising SEQ ID NO: 3 or a fragment thereof comprising at least eight contiguous amino acids, a nucleic acid encoding the anti-viral polypeptide, or an antibody to the anti-viral polypeptide. A method of inhibiting a virus in a sample comprising contacting the sample with an anti-viral griffithsin polypeptide or antibody thereto also is provided.
摘要翻译：一种抑制宿主的病毒感染的方法，包括向宿主施用包含SEQ ID NO：3或其包含至少八个连续氨基酸的片段的抗病毒核糖蛋白多肽，编码抗病毒多肽的核酸，或抗病毒多肽的抗体。还提供了一种抑制样品中的病毒的方法，其包括使样品与抗病毒性骨灰蛋白酶多肽或其抗体接触。

30. 发明申请

US20110275620A1 Method for preventing or treating a disease related to the glucocorticoid receptor 有权
标题翻译：预防或治疗与糖皮质激素受体有关的疾病的方法
公开(公告)号：US20110275620A1
公开(公告)日：2011-11-10
申请号：US13135790
申请日：2011-07-14
申请人： Mamoru Matsuda , Masato Nagatsuka , Toshiyuki Mori , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
发明人： Mamoru Matsuda , Masato Nagatsuka , Toshiyuki Mori , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
IPC分类号： A61K31/541 , A61K31/47 , A61K31/5377 , A61K31/497 , A61P9/12 , A61P3/10 , A61P25/28 , A61P25/00 , A61P9/10 , A61K31/4709 , A61P3/04
CPC分类号： C07D401/12 , C07D215/14 , C07D405/12 , C07D409/12 , C07D409/14 , C07D417/12
摘要： A method for preventing or treating a disease related to the glucocorticoid receptor involving administering a pharmacologically effective amount of a 1,2-hydroquinoline compound.
摘要翻译：一种预防或治疗涉及糖皮质激素受体的疾病的方法，包括施用药理学有效量的1,2-氢喹啉化合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式